Diagnostic categories defined by the Amyloid-Tau-Neurodegeneration system within the continuum of the biological definition of Alzheimer’s disease, according to the 2018 National Institute on Aging and the Alzheimer’s Association Research Framework43,44. The gene discussed is MAPT; the disease is Alzheimer disease.